Top Biotechnology & Medical Research stocks in Australasia
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
TLXTelix Pharmaceuticals | AU$5.86bn | 1021.46 | n/a |
CU6Clarity Pharmaceuticals | AU$1.47bn | n/a | n/a |
MSBMesoblast | AU$1.01bn | n/a | n/a |
PYCPYC Therapeutics | AU$447.94m | n/a | n/a |
OPTOpthea | AU$416.10m | n/a | n/a |
IMUImugene | AU$394.30m | n/a | n/a |
IMMImmutep | AU$391.57m | n/a | n/a |
RACRace Oncology | AU$297.56m | n/a | n/a |
DXBDimerix | AU$225.87m | n/a | n/a |
CGSCogstate | AU$191.93m | 25.22 | n/a |
ACWActinogen Medical | AU$153.89m | n/a | n/a |
ALAArovella Therapeutics | AU$127.35m | n/a | n/a |
LTPLtr Pharma | AU$119.90m | n/a | n/a |
PIQProteomics International Laboratories | AU$106.43m | n/a | n/a |
PARParadigm Biopharmaceuticals | AU$101.93m | n/a | n/a |
AGNArgenica Therapeutics | AU$77.59m | n/a | n/a |
PERPercheron Therapeutics | AU$72.12m | n/a | n/a |
PEBPacific Edge | NZ$74.64m | n/a | n/a |
NTINeurotech International | AU$63.31m | n/a | n/a |
CYPCynata Therapeutics | AU$52.99m | n/a | n/a |